Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
169.98
Oct 30 • 3:59 PM ET Dollar change-0.42 Percentage change(-0.25%)
Aftermarket Close
169.98
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
5.40B
Enterprise Value
5.48B
Income
170.85M
Sales
1.11B
Book/sh
41.69
Cash/sh
2.09
Employees
1352
IPO
Jun 03, 1986
P/E
32.04
Forward P/E
29.73
PEG
3.97
P/S
4.87
P/B
4.08
P/C
81.52
P/FCF
30.35
EV/EBITDA
19.07
EV/Sales
4.94
Quick Ratio
1.39
Current Ratio
2.47
Debt/Eq
0.11
LT Debt/Eq
0.10
Option/Short
Yes / Yes
EPS (ttm)
5.31
EPS next Y
5.72
EPS next Q
1.41
EPS this Y
15.37%
EPS next Y
4.32%
EPS next 5Y
7.49%
EPS past 3/5Y
13.45% 12.78%
Sales past 3/5Y
3.25% 8.07%
EPS Y/Y TTM
16.31%
Sales Y/Y TTM
9.42%
EPS Q/Q
18.02%
Sales Q/Q
8.63%
Insider Own
0.55%
Insider Trans
0.00%
Inst Own
91.64%
Inst Trans
0.89%
ROA
10.16%
ROE
13.02%
ROIC
11.66%
Gross Margin
36.46%
Oper. Margin
21.54%
Profit Margin
15.41%
SMA20
0.20%
SMA50
-0.11%
SMA200
0.42%
Trades
Shs Outstand
31.82M
Shs Float
31.60M
52W High
183.90 -7.57%
52W Low
147.18 15.49%
Volatility
2.79% 2.11%
ATR (14)
3.62
RSI (14)
50.43
Beta
0.85
Rel Volume
1.07
Avg Volume
232.54K
Volume
249,328
Perf Week
-3.97%
Perf Month
3.84%
Perf Quarter
-2.07%
Perf Half Y
5.24%
Perf YTD
10.84%
Perf Year
10.40%
Perf 3Y
47.07%
Perf 5Y
11.03%
Perf 10Y
124.93%
Prev Close
170.40
Price
169.98
Change %
-0.25%
Consensus
Buy
Avg. Price Target
$213.50
Implied Upside
+25.6%
Analysts8incl. previous ratings
Rating Distribution3 Buy · 5 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 05, 2025Initiated
RRothschild & Co Redburn
Neutral$162-4.7%
Feb 22, 2022Upgrade
SSidoti
Neutral → Buy$175+3.0%
Nov 29, 2021Downgrade
SSidoti
Buy → Neutral$175+3.0%
Aug 02, 2021Downgrade
SStephens
Overweight → Equal-Weight$140 → $145-14.7%
Feb 22, 2021Upgrade
SStephens
Equal-Weight → Overweight
Aug 04, 2020Reiterated
HH.C. Wainwright
Buy$104 → $126-25.9%
Jul 10, 2020Initiated
SStephens
Equal-Weight$100-41.2%
Feb 24, 2020Reiterated
HH.C. Wainwright
Buy$122 → $116-31.8%
May 06, 2019Downgrade
PPivotal Research Group
Buy → Hold$100-41.2%
Feb 21, 2019Initiated
SSeaport Global Securities
Neutral
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fischer David BDirectorDec 03 '25Option Exercise78.726,000472,33415,989Dec 05 04:28 PM
Fischer David BDirectorDec 03 '25Sale153.978,0001,231,7487,989Dec 05 04:28 PM
van Gunsteren Job LeonardSVP and GM, Specialty ProductsDec 04 '25Option Exercise60.856,000365,10015,446Dec 05 04:23 PM
van Gunsteren Job LeonardSVP and GM, Specialty ProductsDec 04 '25Sale153.296,000919,7239,446Dec 05 04:23 PM
van Gunsteren Job LeonardOfficerDec 04 '25Proposed Sale153.296,000919,722Dec 04 05:08 PM
Fischer David BDirectorDec 03 '25Proposed Sale153.916,000923,458Dec 03 05:05 PM
Fischer David BDirectorDec 03 '25Proposed Sale154.202,000308,400Dec 03 05:03 PM
Reid Martin LutherSVP Chief Supply Chain OfficerNov 11 '25Sale154.441,200185,3287,391Nov 13 04:15 PM
Reid Martin LutherOfficerNov 11 '25Proposed Sale154.441,200185,328Nov 12 01:14 PM
Balchem Corp. markets specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in 1967 and is headquartered in Montvale, NJ.
CEOMr. Theodore Lee Harris
Executive VPMr. Carl Martin Bengtsson
Executive VPMs. Hatsuki Miyata J.D.
Senior VP & Chief Human Resources OfficerMr. M. Brent Tignor
Senior VPMr. Frederic Boned